While at Hugging Face, engineers Mark McQuade and Brian Benedict faced challenges in helping enterprise clients integrate Generative AI (GenAI). Many organizations hesitated to use closed-source AI APIs due to concerns about transparency, while also wary of open-source models over security risks.
"We quickly recognized that the main issue was addressing the trust deficit in current generative AI systems," McQuade shared in a recent email interview. "This primarily relates to performance and security."
With experience from Rackspace and the computer vision startup Roboflow, McQuade sought solutions beyond existing options. After finding none satisfactory, he teamed up with Roboflow's head of machine learning, Jacob Salowetz, and Benedict to create a platform that enables organizations to build and train GenAI models within a secure computing environment.
Launched as Arcee in February, the platform has garnered $5.5 million in venture funding from investors like Long Journey Ventures, Flybridge, Centre Street Partners, Wndrco, 35V, AIN Ventures, and Hugging Face CEO Clément Delangue.
“Arcee is transforming AI for highly regulated sectors such as legal, healthcare, insurance, and financial services,” McQuade stated. “Our platform empowers these industries and any organization handling sensitive data to build specialized language models securely using their own data within their cloud environment.”
As the GenAI market flourishes, numerous startups are emerging to address the challenge McQuade highlights: creating secure and efficient private enterprise models. For instance, Contextual AI provides tools to customize GenAI models, particularly large language models similar to OpenAI’s ChatGPT. Meanwhile, Giga ML focuses on enabling offline deployment of these models, and Reka specializes in crafting custom models for business applications, including document analysis.
So how does Arcee set itself apart? McQuade notes several key differentiators.
Firstly, Arcee offers an end-to-end platform that utilizes an “adaptive” system for training, deploying, and monitoring GenAI models. Furthermore, it operates within a virtual private cloud, providing what McQuade describes as “superior” fine-tuning and security to minimize privacy risks.
Emphasizing security is crucial, especially since surveys indicate it is a top concern for enterprises. A recent Salesforce poll found that 71% of IT leaders anticipate generative AI will introduce new security threats to their data.
“Arcee’s method allows organizations to construct and refine these models in their secure environments,” McQuade explained. “This ensures data privacy and gives businesses complete ownership of their AI models and technology stack.”
While it’s true that Arcee’s platform may have advantages over competitors, it still faces the challenge of navigating a crowded market for GenAI development platforms. Established players like Google, Microsoft, and Amazon also compete within this space, exemplified by Google’s Vertex AI.
Despite this competitive landscape, Arcee's early investors remain confident. Flybridge's Jesse Middleton expressed this belief via email: "Our decision to invest in Arcee was driven by three compelling factors. First, analysts see that only 2.5% of enterprise software spending is currently on AI applications. This expanding AI market, especially in industry-specific solutions, positions Arcee as a potential standout. Second, the team’s expertise and success in securing multiple Global 2000 clients show a deep understanding of market needs. Lastly, the current AI environment necessitates innovative solutions like Arcee’s, making this an ideal time to invest in the future of AI and tailored language models across various enterprise divisions."
However, a pressing question looms: is there high enough demand for GenAI in enterprises to sustain another platform? This concern is valid.
A Boston Consulting Group survey of over 1,400 C-suite executives found that only about half expect GenAI to yield significant productivity gains in their organizations. Furthermore, more than half of executive decision-makers expressed hesitation towards GenAI adoption, citing fears of potential unethical decision-making and data security vulnerabilities.
Nevertheless, McQuade firmly believes that Arcee can not only stand out but thrive with the right customer and investor backing. He affirms that the funding raised thus far will facilitate workforce expansion, enhance the platform, and penetrate new markets.
"Our clients' responses have demonstrated that we are not merely filling a market gap but leading in AI innovation," McQuade stated, opting not to disclose specific client identities. "We are dedicated to creating value for our investors, partners, and customers, focusing on our technological and market progress rather than on specific financial metrics."
This confidence isn't unfounded, especially regarding investments. According to PitchBook, venture capitalists invested $21.4 billion in GenAI startups last year through September, a significant jump from $5.1 billion in 2022. If 2024 follows suit, funding should continue to flow in this burgeoning sector.
Ranking
